Literature DB >> 20164853

AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions.

C Haferlach, F Dicker, A Kohlmann, S Schindela, T Weiss, W Kern, S Schnittger, T Haferlach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20164853     DOI： 10.1038/leu.2010.22

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  23 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

Review 2.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  Intergenically Spliced Chimeric RNAs in Cancer.

Authors:  Yuemeng Jia; Zhongqiu Xie; Hui Li
Journal:  Trends Cancer       Date:  2016-09

4.  The genomic landscape of core-binding factor acute myeloid leukemias.

Authors:  Zachary J Faber; Xiang Chen; Amanda Larson Gedman; Kristy Boggs; Jinjun Cheng; Jing Ma; Ina Radtke; Jyh-Rong Chao; Michael P Walsh; Guangchun Song; Anna K Andersson; Jinjun Dang; Li Dong; Yu Liu; Robert Huether; Zhongling Cai; Heather Mulder; Gang Wu; Michael Edmonson; Michael Rusch; Chunxu Qu; Yongjin Li; Bhavin Vadodaria; Jianmin Wang; Erin Hedlund; Xueyuan Cao; Donald Yergeau; Joy Nakitandwe; Stanley B Pounds; Sheila Shurtleff; Robert S Fulton; Lucinda L Fulton; John Easton; Evan Parganas; Ching-Hon Pui; Jeffrey E Rubnitz; Li Ding; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Charles G Mullighan; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Lars Bullinger; Jinghui Zhang; Jeffery M Klco; James R Downing
Journal:  Nat Genet       Date:  2016-10-31       Impact factor: 38.330

5.  CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia.

Authors:  A Mandoli; A A Singh; P W T C Jansen; A T J Wierenga; H Riahi; G Franci; K Prange; S Saeed; E Vellenga; M Vermeulen; H G Stunnenberg; J H A Martens
Journal:  Leukemia       Date:  2013-09-04       Impact factor: 11.528

Review 6.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

7.  High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.

Authors:  Michael W M Kühn; Ina Radtke; Lars Bullinger; Salil Goorha; Jinjun Cheng; Jennifer Edelmann; Juliane Gohlke; Xiaoping Su; Peter Paschka; Stanley Pounds; Jürgen Krauter; Arnold Ganser; Asmaa Quessar; Raul Ribeiro; Verena I Gaidzik; Sheila Shurtleff; Jan Krönke; Karlheinz Holzmann; Jing Ma; Richard F Schlenk; Jeffrey E Rubnitz; Konstanze Döhner; Hartmut Döhner; James R Downing
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

8.  Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.

Authors:  Gautam Borthakur; Leslie Popplewell; Michael Boyiadzis; James Foran; Uwe Platzbecker; Norbert Vey; Roland B Walter; Rebecca Olin; Azra Raza; Aristoteles Giagounidis; Aref Al-Kali; Elias Jabbour; Tapan Kadia; Guillermo Garcia-Manero; John W Bauman; Yuehui Wu; Yuan Liu; Dan Schramek; Donna S Cox; Paul Wissel; Hagop Kantarjian
Journal:  Cancer       Date:  2016-03-18       Impact factor: 6.860

9.  NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.

Authors:  Liting Xue; John A Pulikkan; Peter J M Valk; Lucio H Castilla
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

10.  UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.

Authors:  S Goyama; J Schibler; A Gasilina; M Shrestha; S Lin; K A Link; J Chen; S P Whitman; C D Bloomfield; D Nicolet; S A Assi; A Ptasinska; O Heidenreich; C Bonifer; T Kitamura; N N Nassar; J C Mulloy
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.